Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

UCSF taps Selick for BD position

April 25, 2017 10:54 PM UTC

The University of California San Francisco named Barry Selick vice chancellor for business development, innovation and partnerships. Selick resigned last month as CEO of Threshold Pharmaceuticals Inc. (NASDAQ:THLD).

The university said Selick will oversee proof-of-concept studies to determine which therapies, diagnostics or software are most likely to help patients. He will also lead UCSF's Industry Alliances and Program Management, Office of Technology Management, Catalyst Program, and its Entrepreneurship Center. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article